Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
Jing Dai, Shuzheng Lyu, Chang-Jiang Ge
openalex +1 more source
Letter by Hnid and Chtioui Regarding Article, “Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction: Results From the French Registry of Acute ST-Elevation and Non–ST-Elevation Myocardial Infarction (FAST-MI) Registry” [PDF]
Karim Hnid, M. Chtioui
openalex +1 more source
Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function [PDF]
Stefan James +15 more
openalex +1 more source
Advanced age and high‐residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor [PDF]
Monica Verdoia +9 more
openalex +1 more source
A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation [PDF]
Yae Min Park +10 more
openalex +1 more source
Discontinuation of aspirin, warfarin and clopidogrel, and stroke recurrence in Medicaid patients [PDF]
F.T. Shaya +3 more
openalex +1 more source
Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting† [PDF]
Antonio Miceli +7 more
openalex +1 more source
Clopidogrel versus Acetylsalicylsäure in der Sekundärprophylaxe vaskulärer Erkrankungen: Ein Kommentar zum Bericht des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen [PDF]
Heinrich P. Mattle, Kurt Niederkorn
openalex
ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
S. J. Martsevich
openalex +2 more sources

